Shapira MY - Search Results

1

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.

Tsirigotis P, Bitan RO, Resnick IB, Samuel S, Ackerstein A, Eladì S, Gesundheit B, Zilberman I, Miron S, Leubovic A, Slavin S, Shapira MY. Tsirigotis P, et al. Among authors: shapira my. Haematologica. 2006 Jun;91(6):852-5. Haematologica. 2006. PMID: 16769592

2

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma.

Tsirigotis P, Dray L, Resnick IB, Ackerstein A, Gesundheit B, Elad S, Or R, Shapira MY. Tsirigotis P, et al. Among authors: shapira my. Ann Hematol. 2010 Mar;89(3):263-72. doi: 10.1007/s00277-009-0808-5. Epub 2009 Aug 20. Ann Hematol. 2010. PMID: 19693502 Clinical Trial.

3

Post-hematopoietic stem cell transplantion immune-mediated cytopenias.

Tsirigotis PD, Resnick IB, Or R, Elad S, Zilberman I, Yoffe L, Levovic A, Miron S, Gesundheit B, Slavin S, Shapira MY. Tsirigotis PD, et al. Among authors: shapira my. Immunotherapy. 2009 Jan;1(1):39-47. doi: 10.2217/1750743X.1.1.39. Immunotherapy. 2009. PMID: 20635972

4

Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease.

Tsirigotis P, Or R, Resnick IB, Shapira MY. Tsirigotis P, et al. Among authors: shapira my. Immunotherapy. 2012 Apr;4(4):407-24. doi: 10.2217/imt.12.14. Immunotherapy. 2012. PMID: 22512635 Review.

5

Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.

Or R, Aker M, Shapira MY, Resnick I, Bitan M, Samuel S, Slavin S. Or R, et al. Among authors: shapira my. Springer Semin Immunopathol. 2004 Nov;26(1-2):133-42. doi: 10.1007/s00281-004-0169-z. Epub 2004 Sep 30. Springer Semin Immunopathol. 2004. PMID: 15549305 Review.

6

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S. Or R, et al. Among authors: shapira my. Blood. 2003 Jan 15;101(2):441-5. doi: 10.1182/blood-2002-02-0535. Epub 2002 Sep 19. Blood. 2003. PMID: 12393604 Free article.

7

Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.

Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, Or R. Slavin S, et al. Among authors: shapira my. Semin Oncol. 2004 Feb;31(1):4-21. doi: 10.1053/j.seminoncol.2003.10.016. Semin Oncol. 2004. PMID: 14970932 Review.

8

Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R. Slavin S, et al. Among authors: shapira my. Clin Transpl. 2003:275-82. Clin Transpl. 2003. PMID: 15387119 Review.

9

Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells.

Bitan M, Shapira MY, Resnick IB, Zilberman I, Miron S, Samuel S, Ackerstein A, Elad S, Israel S, Amar A, Fibach E, Or R, Slavin S. Bitan M, et al. Among authors: shapira my. Exp Hematol. 2005 Jun;33(6):713-8. doi: 10.1016/j.exphem.2005.03.004. Exp Hematol. 2005. PMID: 15911096 Free article.

10

Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.

Bitan M, Or R, Shapira MY, Resnick IB, Ackerstein A, Samuel S, Elad S, Slavin S. Bitan M, et al. Among authors: shapira my. Haematologica. 2005 Aug;90(8):1089-95. Haematologica. 2005. PMID: 16079108 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters